Bokf Na Has $2.93 Million Stock Position in The Clorox Company (NYSE:CLX)

Bokf Na decreased its holdings in The Clorox Company (NYSE:CLX) by 26.0% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,349 shares of the company’s stock after selling 6,803 shares during the quarter. Bokf Na’s holdings in Clorox were worth $2,934,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of CLX. Vanguard Group Inc. grew its stake in shares of Clorox by 0.3% during the first quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after purchasing an additional 48,632 shares during the period. Point72 Asset Management L.P. bought a new stake in Clorox in the 4th quarter valued at approximately $144,844,000. Norges Bank bought a new position in shares of Clorox in the 4th quarter valued at about $128,382,000. Parsifal Capital Management LP bought a new position in shares of Clorox in the 4th quarter valued at about $128,245,000. Finally, Confluence Investment Management LLC bought a new position in shares of Clorox during the 1st quarter worth approximately $135,630,000. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

Shares of NYSE:CLX traded down $1.76 on Monday, hitting $132.85. The company’s stock had a trading volume of 136,803 shares, compared to its average volume of 1,224,905. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.14. The company has a market capitalization of $16.50 billion, a PE ratio of 69.75, a PEG ratio of 1.98 and a beta of 0.39. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The company has a 50-day simple moving average of $133.71 and a 200 day simple moving average of $142.67.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping the consensus estimate of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period last year, the firm posted $1.51 earnings per share. The business’s revenue was down 5.3% compared to the same quarter last year. Sell-side analysts forecast that The Clorox Company will post 5.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

CLX has been the topic of a number of recent research reports. DA Davidson reaffirmed a “neutral” rating and set a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. Argus raised Clorox to a “hold” rating in a research report on Tuesday, June 4th. JPMorgan Chase & Co. reduced their price objective on shares of Clorox from $158.00 to $150.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. UBS Group decreased their target price on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Six research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company. Based on data from MarketBeat, Clorox has a consensus rating of “Hold” and an average target price of $142.13.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.